Abstract
The aim of the study was to identify factors influencing long-term outcome and to evaluate the prognostic power of the Status Epilepticus Severity Score (STESS) in refractory status epilepticus (RSE). We retrospectively extracted data on baseline characteristics, RSE details, and hospital course including complications from all patients treated for RSE in our institution between January 2001 and January 2013. Functional outcome was assessed using the modified Rankin Scale (mRS) and was defined as good when either RSE did not lead to functional decline or when the resulting mRS score was 2 or below. Seventy-one episodes in 65 patients were analyzed. The median follow-up time was 12 weeks (IQR 6–35), two patients were lost to follow-up. Poor functional long-term outcome was observed in 42/69 (60.9 %) episodes. In-hospital mortality occurred in 13/71 (18.3 %) episodes. Multivariable analysis revealed that STESS ≥ 3, longer RSE duration, and sepsis were independently related to poor functional long-term outcome. Receiver operating characteristics (ROC) curve analyses confirmed the cut-off dichotomization into STESS ≥ 3 and STESS < 3 for optimal discrimination between good and poor outcome (AUC = 0.671, p = 0.002, YI = 0.368, NPV = 0.607, PPV = 0.756) and revealed an RSE duration of 10 days as a significant cut-off point associated with outcome (AUC = 0.712, p = 0.012, YI = 0.310; NPV = 0.545, PPV = 0.750). In conclusion, STESS and RSE duration represent relevant scores and parameters impacting long-term outcome after RSE. A shorter RSE duration is associated with better outcome and, therefore, rapid and adequate treatment for seizure termination should be enforced.
Similar content being viewed by others
References
Hocker S, Wijdicks EF, Rabinstein AA (2013) Refractory status epilepticus: new insights in presentation, treatment, and outcome. Neurol Res 35(2):163–168. doi:10.1179/1743132812Y.0000000128
Lowenstein DH (2006) The management of refractory status epilepticus: an update. Epilepsia 47(Suppl 1):35–40. doi:10.1111/j.1528-1167.2006.00658.x
Holtkamp M, Othman J, Buchheim K, Meierkord H (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 76(4):534–539. doi:10.1136/jnnp.2004.041947
Rossetti AO, Logroscino G, Bromfield EB (2005) Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 62(11):1698–1702. doi:10.1001/archneur.62.11.1698
Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA (2013) Predictors of outcome in refractory status epilepticus. JAMA Neurol 70(1):72–77. doi:10.1001/jamaneurol.2013.578
Cooper AD, Britton JW, Rabinstein AA (2009) Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 66(12):1505–1509. doi:10.1001/archneurol.2009.273
Standley K, Abdulmassih R, Benbadis S (2012) Good outcome is possible after months of refractory convulsive status epilepticus: lesson learned. Epilepsia 53(1):e17–e20. doi:10.1111/j.1528-1167.2011.03327.x
Peets AD, Berthiaume LR, Bagshaw SM, Federico P, Doig CJ, Zygun DA (2005) Prolonged refractory status epilepticus following acute traumatic brain injury: a case report of excellent neurological recovery. Crit Care 9(6):R725–R728. doi:10.1186/cc3884
Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kossoff EH, Kaplan PW, Geocadin RG, Hartman AL, Venkatesan A, Cervenka MC (2014) Ketogenic diet for adults in super-refractory status epilepticus. Neurology 82(8):665–670. doi:10.1212/WNL.0000000000000151
Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW (2011) A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 14(1):4–10. doi:10.1007/s12028-010-9445-z
Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB (2008) Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol 255(10):1561–1566. doi:10.1007/s00415-008-0989-1
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17(1):3–23. doi:10.1007/s12028-012-9695-z
Sutter R, Marsch S, Fuhr P, Ruegg S (2013) Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study. Epilepsia 54(3):502–511. doi:10.1111/epi.12064
Lowenstein DH, Bleck T, Macdonald RL (1999) It’s time to revise the definition of status epilepticus. Epilepsia 40(1):120–122
Holtkamp M (2011) Treatment strategies for refractory status epilepticus. Current opinion in critical care 17(2):94–100. doi:10.1097/MCC.0b013e328342fab5
Pugin D, Foreman B, De Marchis GM, Fernandez A, Schmidt JM, Czeisler BM, Mayer SA, Agarwal S, Lesch C, Lantigua H, Claassen J (2014) Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care 18(3):R103. doi:10.1186/cc13883
Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S (2014) Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 82(8):656–664. doi:10.1212/WNL.0000000000000009
Guidelines for epidemiologic studies on epilepsy (1993) Commission on Epidemiology and Prognosis, International League Against Epilepsy Epilepsia 34(4):592–596
Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB (2006) Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 77(5):611–615. doi:10.1136/jnnp.2005.080887
Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL (2009) Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 50(6):1566–1571. doi:10.1111/j.1528-1167.2008.01993.x
Rankin J (1957) Cerebral vascular accidents in patients over the age of 60 II. Prognosis. Scottish Med J 2(5):200–215
Kowalski RG, Ziai WC, Rees RN, Werner JK Jr, Kim G, Goodwin H, Geocadin RG (2012) Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 40(9):2677–2684. doi:10.1097/CCM.0b013e3182591ff1
Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 59(2):205–210
Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J (2004) Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 45(7):757–763. doi:10.1111/j.0013-9580.2004.01904.x
Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, Meyers E, Espinera A, Haas KF, Schmitt SE, Gerard EE, Gofton T, Kaplan PW, Lee JW, Legros B, Szaflarski JP, Westover BM, LaRoche SM, Hirsch LJ (2015) New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology. doi:10.1212/WNL.0000000000001940
Sutter R, Kaplan PW, Ruegg S (2013) Independent external validation of the status epilepticus severity score. Crit Care Med 41(12):e475–e479. doi:10.1097/CCM.0b013e31829eca06
Rossetti AO, Logroscino G, Bromfield EB (2006) A clinical score for prognosis of status epilepticus in adults. Neurology 66(11):1736–1738. doi:10.1212/01.wnl.0000223352.71621.97
Sutter R, Grize L, Fuhr P, Ruegg S, Marsch S (2013) Acute-phase proteins and mortality in status epilepticus: a 5-year observational cohort study. Crit Care Med 41(6):1526–1533. doi:10.1097/CCM.0b013e318287f2ac
Vezzani A, Friedman A, Dingledine RJ (2013) The role of inflammation in epileptogenesis. Neuropharmacology 69:16–24. doi:10.1016/j.neuropharm.2012.04.004
Marchi NA, Novy J, Faouzi M, Stahli C, Burnand B, Rossetti AO (2015) Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. doi:10.1097/CCM.0000000000000881
Claassen J, Hirsch LJ, Emerson RG, Mayer SA (2002) Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 43(2):146–153
Lai A, Outin HD, Jabot J, Megarbane B, Gaudry S, Coudroy R, Louis G, Schneider F, Barbarot N, Roch A, Lerolle N, Luis D, Fourrier F, Renault A, Argaud L, Sharshar T, Gibot S, Bollaert PE (2015) Functional outcome of prolonged refractory status epilepticus. Crit Care 19:199. doi:10.1186/s13054-015-0914-9
Sutter R, Kaplan PW, Marsch S, Hammel EM, Ruegg S, Ziai WC (2015) Early predictors of refractory status epilepticus: an international two-center study. Euro J Neurol Off J Euro Feder Neurol Soci 22(1):79–85. doi:10.1111/ene.12531
Acknowledgments
This work was supported by a research grant (ELAN-13-07-15-1) from the ELAN Fonds University of Erlangen-Nuremberg, Germany. We would like to thank Inken Martin, MD, PhD (Victor Chang Cardiac Research Institute, Sydney, Australia) for critically proofreading the manuscript as well as Olaf Bergmann, MD, PhD (Karolinska Institute, Stockholm, Sweden) for valuable discussions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflicts of interest relevant to this study.
Ethical standard
The study was approved by the local institutional review board (Ethics Committee Vote: 48_15Bc).
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Madžar, D., Geyer, A., Knappe, R.U. et al. Association of seizure duration and outcome in refractory status epilepticus. J Neurol 263, 485–491 (2016). https://doi.org/10.1007/s00415-015-7992-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-015-7992-0